-
Introduction of FDA Regulatory Education for Industry (REdI) Annual Conference 2021
Lin Zhang
August 16, 2021
There are many educational events in FDA throughout the year that focus on the pharmaceutical and regulatory industries.
-
Pharmaceutical News of the Week | CPhI.CN - Volumn-based Procurement
PharmaSources/Caicai
August 06, 2020
According to the key content spread on the internet on July 28 regarding the national centralized procurement meeting held on July 24.
-
I-Mab Expands U.S. Footprint with New R&D Site in San Diego
prnasia
October 25, 2021
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that...
-
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
prnasia
September 23, 2021
Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases.
-
Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing
contractpharma
August 12, 2021
Lumen Bioscience, a clinical-stage biopharma company, announced results from a research collaboration with Google that applied machine learning (ML) to significantly advance the scalability of spirulina-based biologic drugs.
-
Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy
contractpharma
July 22, 2021
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
-
Fujifilm Invests $850M to Expand Biologics Capabilities
contractpharma
July 02, 2021
Investment in CDMO business to add development and manufacturing capacity in US and UK.
-
Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics
contractpharma
May 08, 2021
New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.
-
Kemwell Biopharma increases capacity for manufacturing of biologics
expresspharma
April 28, 2021
The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical toxicology batch and early cGMP clinical trial supplies at 250L to 1000L scale in its current facility.
-
Biologics CDMO market to double in value by 2026, suggests report
europeanpharmaceuticalreview
April 16, 2021
Research suggests the increasing R&D investment in and adoption of biologics will drive growth in the global biologics contract development and manufacturing organisation (CDMO) market.